Cigna Group Net Income/Loss 2012-2026 | CI

Cigna Group annual/quarterly net income/loss history and growth rate from 2012 to 2026. Net income/loss can be defined as the company's total income or loss before preferred stock dividends, taken from the Income Statement
  • Cigna Group net income/loss for the quarter ending March 31, 2026 was $5.014B, a 123.64% increase year-over-year.
  • Cigna Group net income/loss for the twelve months ending March 31, 2026 was $13.242B, a 50.15% increase year-over-year.
  • Cigna Group annual net income/loss for 2024 was $3.778B, a 29.67% decline from 2023.
  • Cigna Group annual net income/loss for 2023 was $5.372B, a 20.79% decline from 2022.
  • Cigna Group annual net income/loss for 2022 was $6.782B, a 25.13% increase from 2021.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Cigna Group Annual Net Income/Loss
(Millions of US $)
2024 $3,778
2023 $5,372
2022 $6,782
2021 $5,420
2020 $8,489
2019 $5,120
2018 $2,646
2017 $2,232
2016 $1,843
2015 $2,077
2014 $2,094
2013 $1,478
2012 $1,624
2011 $1,261
Sector Industry Market Cap Revenue
Medical Medical - Health Maintenance Organizations $71.482B $274.900B
The Cigna Group, together with its subsidiaries, provides insurance and related products and services principally in the United States. The Cigna Group, formerly known as Cigna Corporation, is based in Bloomfield, Connecticut.
Stock Name Country Market Cap PE Ratio
UnitedHealth Group (UNH) United States $276.233B 18.66
Humana (HUM) United States $23.068B 11.22
Centene (CNC) United States $18.343B 18.19
Molina Healthcare (MOH) United States $7.599B 13.70
Select Medical Holdings (SEM) United States $2.030B 14.23
Joint (JYNT) United States $0.125B 0.00
Aethlon Medical (AEMD) United States $0.003B 0.00